Get all your news in one place.

100’s of premium titles.
One app.

Start reading

Get all your news in one place.

100’s of premium titles. One news app.

Start reading

The Latest Breaking News from Eli Lilly

Another weight loss jab approved for NHS use

The once-weekly jab was hailed as a ‘much-needed addition to other available treatments’

The Independent UK

Weight loss jab recommended to treat type 2 diabetes

The once-weekly jab was hailed as a ‘much-needed addition to other available treatments’

The Independent UK

Chart of the Day: Eli Lilly (LLY) Edges to New Record High

The Barchart Chart of the Day belongs to Eli Lilly (LLY) . I found the stock by using Barchart.com to find the "Barchart New Highs" page, and then I clicked on pull-down to select stocks with new 52-week highs. I then viewed the stocks on the list with the FlipCharts...

Barchart

From analysis to the latest developments in health,
read the most diverse news in one place.

Warren Buffett Bets His Fortune On One Of 9 'Can't Lose' Stocks

What do investors do when they can get 5% for taking no risk? Find S&P 500 stocks they can make even more on by taking little risk — a tall order only a few can meet.

Investors Business Daily

How Novo Nordisk, A Top 1% Stock, Just Hit Another Bull's-eye In Obesity Treatment

Novo Nordisk said Friday its obesity treatment, Wegovy, reduced heart-failure symptoms. But Novo Nordisk stock remained flat.

Investors Business Daily

You're An Amazing Picker If You Bought These 8 Stocks This Month

The S&P 500's plunge in August caught most investors off guard. It's quite a win if you scooped up the handful of gainers in the tough month.

Investors Business Daily

A trial to test a new path for preventing Alzheimer’s

Alzheimer research made a breakthrough last month when Eli Lilly's drug donanemab slowed cognitive decline in 47% of those taking it. It follows two other drugs, lecanemab and aducanumab, that target amyloid protein buildup in the brain. However, these drugs can cause fatal brain bleeding and seizures. Oxidative stress hypothesis…

The Hindu

Read news from The Economist, FT, and more,
with one subscription

Why This Nugget Of Bad Weight-Loss News Isn't Weighing On Lilly, Novo

Prescriptions of weight-loss and diabetes drugs have rocketed this year, giving Novo Nordisk stock and Eli Lilly stock more room to run.

Investors Business Daily

Insulin Patients Can Find Discounts With Amazon's New Automated Coupon System

Amazon Pharmacy will automatically apply manufacturer-sponsored coupons for 15-plus products.

Kiplinger

Market Rally On The Ropes, AI Stocks Tumble: Weekly Review

The market rally suffered more damage as the Nasdaq undercut key support and many leading AI stocks sold off hard.

Investors Business Daily

Is Eli Lilly Stock A Buy Or A Sell After Its Weight-Loss Drug Scores A Major Victory?

Eli Lilly stock is trading below its key moving averages, but Zepbound just won a new approval. Is LLY stock now a buy?

Investors Business Daily

Tesla Hires New Exec To Lead Giga Nevada's Massive $3.6B Expansion

Before joining Tesla in July, Michael Hildebrand was executive director of projects at Eli Lilly, where he spent the previous 19 years of his career.

InsideEVs

Dow Jones Futures Rise After Market Rally Holds Support; Two Big AI Losers

The market rally faces a key test. Nvidia is holding strong, but some Magnificent 7 stocks are ailing. Two AI plays dived late.

Investors Business Daily

Stock Market Today: Stocks Drop on Troubling China Data, Bank Ratings Worries

The main benchmarks fell Tuesday, but healthcare stocks outperformed as Eli Lilly and Novo Nordisk surged.

Kiplinger

Get all your
news in one place.

100’s of premium titles.
One news app.

The Independent UK

Soaring sales of diabetes drug Mounjaro, often used for weight loss, sends Eli Lilly to new heights

Eli Lilly’s diabetes treatment Mounjaro, which is widely used for weight loss, raked in nearly $1 billion in second-quarter sales, or more than $200 million above what Wall Street had expected

Investors Business Daily

Eli Lilly Surges 15% After Diabetes Powerhouse Mounjaro Fuels Beat And Raise

Eli Lilly stock broke out bullishly Tuesday after the drugmaker walloped forecasts partly due to diabetes treatment powerhouse Mounjaro.

Investors Business Daily

Dow Jones Dives 450 Points On Moody's Bank Downgrades; Palantir Plunges On Earnings

The Dow Jones Industrial Average dived 450 points Tuesday on Moody's bank downgrades. Hot AI stock Palantir Technologies dived on second-quarter earnings results.

WEKU

Ozempic and Wegovy maker courts prominent Black leaders to get Medicare's favor

Drugmaker Novo Nordisk focuses on Black lawmakers and opinion leaders to spread the message that obesity is a chronic disease — worth treating at a cost of $1,000 or more a month.

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

AI Stock Marvell And Eli Lilly Lead 5 Names Near Buy Points As S&P 500 Rallies On

Top AI stock Marvell Technology and Eli Lilly lead this weekend's watch list of five stocks near buy points as the new S&P 500 bull market revs back up.

The Street

Jim Cramer Goes Off On One Popular Investing Method

Make sure you aren't making this common investing mistake when it comes to stocks.

Investors Business Daily

Biogen Stock Tumbles On Plans To Cut 11% Of Workforce; Tops Second-Quarter Estimates

Biogen stock dropped Tuesday after the biotechnology firm said it's eliminating 1,000 jobs as part of a strategy to cut operating expenses.

The Conversation

The obesity epidemic is fuelled by biology, not lack of willpower

Since the time a human first used a tool to make life easier, increased weight has been inevitable.

Investors Business Daily

IBD Stock Of The Day Novo Nordisk, A Weight-Loss Kingpin, Just Retook Its 50-Day Line

Novo Nordisk stock is Thursday's IBD Stock Of The Day. Shares bounded above their 50-day line, giving investors a new entry.

The Conversation

Alzheimer's drug donanemab has been hailed as a 'turning point' for treatment. But what does it mean for people with the disease?

Trial results of a new drug to treat Alzheimer’s disease, donanemab, shows it can slow cognitive decline by 35%. The drug has been hailed as a “turning point” in Alzheimer’s treatment.

Investors Business Daily

Dow Jones Futures Rise After Market Rallies On Microsoft AI Push; Netflix, Tesla Earnings On Tap

Microsoft AI pricing fueled the Nasdaq, which is increasingly extended. Netflix and Tesla earnings loom.

1 … 15 16 17 18

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations